Helios as a Potential Biomarker in Systemic Lupus Erythematosus and New Therapies Based on Immunosuppressive Cells.

MLA

París-Muñoz, Andrés, et al. “Helios as a Potential Biomarker in Systemic Lupus Erythematosus and New Therapies Based on Immunosuppressive Cells.” International Journal of Molecular Sciences, vol. 25, no. 1, Jan. 2024, p. 452. EBSCOhost, https://doi.org/10.3390/ijms25010452.

APA

París-Muñoz, A., León-Triana, O., Pérez-Martínez, A., & Barber, D. F. (2024). Helios as a Potential Biomarker in Systemic Lupus Erythematosus and New Therapies Based on Immunosuppressive Cells. International Journal of Molecular Sciences, 25(1), 452. https://doi.org/10.3390/ijms25010452

Chicago

París-Muñoz, Andrés, Odelaisy León-Triana, Antonio Pérez-Martínez, and Domingo F. Barber. 2024. “Helios as a Potential Biomarker in Systemic Lupus Erythematosus and New Therapies Based on Immunosuppressive Cells.” International Journal of Molecular Sciences 25 (1): 452. doi:10.3390/ijms25010452.